Literature DB >> 30710579

The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice.

Carlos Sanz-Garcia1, Kyle L Poulsen1, Damien Bellos2, Han Wang1, Megan R McMullen1, Xiaoxia Li2, Saurabh Chattopadhyay3, Ganes Sen2, Laura E Nagy4.   

Abstract

BACKGROUND & AIMS: Interferon regulatory factor 3 (IRF3) is a transcription factor mediating antiviral responses, yet recent evidence indicates that IRF3 also has critical non-transcriptional functions, including activating RIG-I-like receptors-induced IRF-3-mediated pathway of apoptosis (RIPA) and restricting activity of NF-κB. Using a novel murine model expressing only non-transcriptional IRF3 activity (Irf3S1/S1), we tested the hypothesis that non-transcriptional functions of IRF3 modulate innate immune responses in the Gao-binge (acute-on-chronic) model of alcohol-related liver disease.
METHODS: IRF3 and IRF3-mediated signals were analysed in liver samples from 5 patients transplanted for alcoholic hepatitis and 5 healthy controls. C57BL/6, Irf3-/- and Irf3S1/S1 mice were exposed to Gao-binge ethanol-induced liver injury. IRF3-mediated RIPA was investigated in cultured macrophages.
RESULTS: Phospho-IRF3 and IRF3-mediated signals were elevated in livers of patients with alcoholic hepatitis. In C57BL/6 mice, Gao-binge ethanol exposure activated IRF3 signaling and resulted in hepatocellular injury. Indicators of liver injury were differentially impacted by Irf3 genotype. Irf3-/-, but not Irf3S1/S1, mice were protected from steatosis, elevated alanine/aspartate aminotransferase levels and inflammatory cytokine expression. In contrast, neutrophil accumulation and endoplasmic reticulum stress were independent of genotype. Protection from Gao-binge injury in Irf3-/- mice was associated with an increased ratio of Ly6Clow (restorative) to Ly6Chigh (inflammatory) cells compared to C57BL/6 and Irf3S1/S1 mice. Reduced ratios of Ly6Clow/Ly6Chigh in C57BL/6 and Irf3S1/S1 mice were associated with increased apoptosis in the Ly6Clow population in response to Gao-binge. Activation of primary macrophage cultures with Poly (I:C) induced translocation of IRF3 to the mitochondria, where it associated with Bax and activated caspases 3 and 9, processes indicative of activation of the RIPA pathway.
CONCLUSIONS: Taken together, these data identify that the non-transcriptional function of IRF3 plays an important role in modulating the innate immune environment in response to Gao-binge ethanol exposure, via regulation of immune cell apoptosis. LAY
SUMMARY: Activation of the innate immune system contributes to inflammation in the progression of alcohol-related liver disease, as well as to the resolution of injury. Here we show that the protein IRF3 modulates the innate immune environment of the liver in a mouse model of alcoholic hepatitis. It does this by increasing the apoptotic cell death of immune cells that promote the resolution of injury.
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; Apoptosis; ER stress; IRF3; Neutrophils; Restorative monocytes

Mesh:

Substances:

Year:  2019        PMID: 30710579      PMCID: PMC6462245          DOI: 10.1016/j.jhep.2019.01.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  28 in total

1.  Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.

Authors:  Jan Petrasek; Angela Dolganiuc; Timea Csak; Bharath Nath; Istvan Hritz; Karen Kodys; Donna Catalano; Evelyn Kurt-Jones; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

2.  STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease.

Authors:  Jan Petrasek; Arvin Iracheta-Vellve; Timea Csak; Abhishek Satishchandran; Karen Kodys; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Gyongyi Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-19       Impact factor: 11.205

3.  Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding.

Authors:  Cheng Ji; Ruty Mehrian-Shai; Christine Chan; Ya-Hsuan Hsu; Neil Kaplowitz
Journal:  Alcohol Clin Exp Res       Date:  2005-08       Impact factor: 3.455

Review 4.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

Review 5.  Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death.

Authors:  Arti Parihar; Timothy D Eubank; Andrea I Doseff
Journal:  J Innate Immun       Date:  2010-03-16       Impact factor: 7.349

6.  The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication.

Authors:  Saurabh Chattopadhyay; Michifumi Yamashita; Ying Zhang; Ganes C Sen
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

7.  Mouse model of chronic and binge ethanol feeding (the NIAAA model).

Authors:  Adeline Bertola; Stephanie Mathews; Sung Hwan Ki; Hua Wang; Bin Gao
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

Review 8.  Endotoxemia and gut barrier dysfunction in alcoholic liver disease.

Authors:  Radhakrishna Rao
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

9.  Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver.

Authors:  Jessica I Cohen; Sanjoy Roychowdhury; Patricia M DiBello; Donald W Jacobsen; Laura E Nagy
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.

Authors:  Prakash Ramachandran; Antonella Pellicoro; Madeleine A Vernon; Luke Boulter; Rebecca L Aucott; Aysha Ali; Stephen N Hartland; Victoria K Snowdon; Andrea Cappon; Timothy T Gordon-Walker; Mike J Williams; Donald R Dunbar; Jonathan R Manning; Nico van Rooijen; Jonathan A Fallowfield; Stuart J Forbes; John P Iredale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-24       Impact factor: 11.205

View more
  13 in total

1.  Mitochondrial Double-Stranded RNA in Exosome Promotes Interleukin-17 Production Through Toll-Like Receptor 3 in Alcohol-associated Liver Injury.

Authors:  Jun-Hee Lee; Young-Ri Shim; Wonhyo Seo; Myung-Ho Kim; Won-Mook Choi; Hee-Hoon Kim; Ye Eun Kim; Keungmo Yang; Tom Ryu; Jong-Min Jeong; Hei-Gwon Choi; Hyuk Soo Eun; Seok-Hwan Kim; Hyejin Mun; Je-Hyun Yoon; Won-Il Jeong
Journal:  Hepatology       Date:  2020-05-08       Impact factor: 17.425

2.  IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation.

Authors:  Sonam Popli; Sukanya Chakravarty; Shumin Fan; Anna Glanz; Siddhesh Aras; Laura E Nagy; Ganes C Sen; Ritu Chakravarti; Saurabh Chattopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

3.  Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b.

Authors:  Suraj J Patel; Nan Liu; Sam Piaker; Anton Gulko; Maynara L Andrade; Frankie D Heyward; Tyler Sermersheim; Nufar Edinger; Harini Srinivasan; Margo P Emont; Gregory P Westcott; Jay Luther; Raymond T Chung; Shuai Yan; Manju Kumari; Reeby Thomas; Yann Deleye; André Tchernof; Phillip J White; Guido A Baselli; Marica Meroni; Dario F De Jesus; Rasheed Ahmad; Rohit N Kulkarni; Luca Valenti; Linus Tsai; Evan D Rosen
Journal:  Sci Transl Med       Date:  2022-03-23       Impact factor: 19.319

4.  Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1/p38MAPKα-dependent mechanisms.

Authors:  Jing Ma; Haixia Cao; Robim M Rodrigues; Mingjiang Xu; Tianyi Ren; Yong He; Seonghwan Hwang; Dechun Feng; Ruixue Ren; Peixin Yang; Suthat Liangpunsakul; Jian Sun; Bin Gao
Journal:  JCI Insight       Date:  2020-07-23

Review 5.  Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting.

Authors:  Matias A Avila; Jean-François Dufour; Alexander L Gerbes; Fabien Zoulim; Ramon Bataller; Patrizia Burra; Helena Cortez-Pinto; Bin Gao; Ian Gilmore; Philippe Mathurin; Christophe Moreno; Vladimir Poznyak; Bernd Schnabl; Gyongyi Szabo; Maja Thiele; Mark R Thursz
Journal:  Gut       Date:  2019-12-26       Impact factor: 23.059

6.  Alcohol Consumption Is Associated with Poor Prognosis in Obese Patients with COVID-19: A Mendelian Randomization Study Using UK Biobank.

Authors:  Xiude Fan; Zhengwen Liu; Kyle L Poulsen; Xiaoqin Wu; Tatsunori Miyata; Srinivasan Dasarathy; Daniel M Rotroff; Laura E Nagy
Journal:  Nutrients       Date:  2021-05-10       Impact factor: 5.717

7.  Nontranscriptional Activity of Interferon Regulatory Factor 3 Protects Mice From High-Fat Diet-Induced Liver Injury.

Authors:  Carlos Sanz-Garcia; Megan R McMullen; Saurabh Chattopadhyay; Sanjoy Roychowdhury; Ganes Sen; Laura E Nagy
Journal:  Hepatol Commun       Date:  2019-10-10

8.  High Throughput Screening of FDA-Approved Drug Library Reveals the Compounds that Promote IRF3-Mediated Pro-Apoptotic Pathway Inhibit Virus Replication.

Authors:  Anna Glanz; Karan Chawla; Stephanie Fabry; Gayatri Subramanian; Julie Garcia; Bryanna Jay; Jacob Ciricillo; Ritu Chakravarti; R Travis Taylor; Saurabh Chattopadhyay
Journal:  Viruses       Date:  2020-04-14       Impact factor: 5.048

9.  Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank.

Authors:  Xiude Fan; Zhengwen Liu; Kyle L Poulsen; Xiaoqin Wu; Tatsunori Miyata; Srinivasan Dasarathy; Daniel M Rotroff; Laura E Nagy
Journal:  medRxiv       Date:  2020-11-30

10.  Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease.

Authors:  Anuradha Ratna; Arlene Lim; Zihai Li; Josepmaria Argemi; Ramon Bataller; Gabriela Chiosis; Pranoti Mandrekar
Journal:  Hepatol Commun       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.